Zobrazeno 1 - 10
of 10
pro vyhledávání: '"C. M. Romero-Barco"'
Autor:
N. Mena-Vázquez, C. M. Romero-Barco, M. Rojas-Giménez, R. Redondo, I. Ureña, I. Añón Oñate, P. Morales-Garrido, L. Pérez Albaladejo, M. Velloso Feijoo, M. D. C. Ordoñez Cañizares, S. Manrique Arija
Publikováno v:
Annals of the Rheumatic Diseases. 81:739-740
BackgroundInterstitial lung disease (ILD) is a common condition in patients with connective tissue disease (CTD). It is associated with increased morbidity and mortality. Rituximab (RTX) has been approved for treatment of RA and some recent retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0643fae23397a12271bfe4937994253
https://doi.org/10.1136/annrheumdis-2022-eular.3014
https://doi.org/10.1136/annrheumdis-2022-eular.3014
Autor:
L. Cano Garcia, S. Manrique Arija, M. Vera Rodríguez, R. Redondo, C. M. Romero-Barco, N. Mena-Vázquez
Publikováno v:
Annals of the Rheumatic Diseases. 81:1663.2-1664
BackgroundDepression in rheumatic diseases negatively influences the support network and the perception of company of these patients (1).ObjectivesTo describe how the COVID-19 pandemic affects the social activitiesn patients with chronic rheumatic di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef0a606e221410bb3419c2be2ce5a51a
https://doi.org/10.1136/annrheumdis-2022-eular.447
https://doi.org/10.1136/annrheumdis-2022-eular.447
Autor:
R. Redondo Rodriguez, F. Godoy-Navarrete, P. Morales-Garrido, M. Rojas-Giménez, C. M. Romero-Barco, N. Mena-Vázquez
Publikováno v:
Annals of the Rheumatic Diseases. 81:599.1-599
BackgroundInterstitial Lung Disease (ILD) is the most common lung involvement in rheumatoid arthritis (RA) and leads to increased morbidity and mortality. Some retrospective observational studies suggest that abatacept (ABT) could be effective and sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91cad1504067f533088622b4ab6e33e1
https://doi.org/10.1136/annrheumdis-2022-eular.3166
https://doi.org/10.1136/annrheumdis-2022-eular.3166
Autor:
L. Muñoz-Barrera, C. Perez-Sanchez, A. Escudero Contreras, M. Á. Aguirre-Zamorano, J. Calvo Gutierrez, R. Ortega Castro, M. Romero-Gómez, I. Sanchez-Pareja, M. C. Ábalos-Aguilera, N. Barbarroja Puerto, J. J. Pérez Venegas, D. Ruiz-Montesinos, C. Rodríguez-Escalera, C. M. Romero-Barco, N. Mena-Vázquez, A. Fernandez-Nebro, J. Uceda, J. L. Marenco, E. Collantes Estevez, C. Lopez-Pedrera
Publikováno v:
Annals of the Rheumatic Diseases. 81:475.1-475
BackgroundThe clinical outcome of the most common therapeutic options of rheumatoid arthritis (RA) patients, such as conventional disease-modifying antirheumatic drugs (DMARDs) and TNF inhibitors (TNFi) is still unpredictable, since a high percentage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfdc684e8a8a911a374a6f2ce84cb353
https://doi.org/10.1136/annrheumdis-2022-eular.4466
https://doi.org/10.1136/annrheumdis-2022-eular.4466
Publikováno v:
E3S Web of Conferences; 2021, Vol. 273, p1-7, 7p
Publikováno v:
Annals of the Rheumatic Diseases; 2016 Supplement 2, Vol. 75, p1299-1318, 13p, 1 Diagram, 9 Charts
Publikováno v:
Annals of the Rheumatic Diseases; 2016 Supplement 2, Vol. 75, p1270-1298, 15p, 1 Diagram, 6 Charts, 1 Graph, 1 Map
Publikováno v:
Annals of the Rheumatic Diseases; 2016 Supplement 2, Vol. 75, p897-1263, 298p, 7 Color Photographs, 2 Black and White Photographs, 17 Diagrams, 218 Charts, 106 Graphs
Publikováno v:
Arthritis & Rheumatism; Oct2013 Supplement 10, Vol. 65, pS1-S1331, 1331p
Autor:
Jiménez-Núñez, Francisco, Manrique-Arija, Sara, Ureña-Garnica, Inmaculada, Romero-Barco, Carmen, Panero-Lamothe, Blanca, Descalzo, Miguel, Carmona, Loreto, Rodríguez-Pérez, Manuel, Fernández-Nebro, Antonio
Publikováno v:
Calcified Tissue International; Jul2013, Vol. 93 Issue 1, p62-68, 7p